The pacemaker current: From basics to the clinics

Journal of Cardiovascular Electrophysiology

Volumn 18, Issue 3, 2007, Pages 342-347

  Barbuti, Andrea ^a   Baruscotti, Mirko ^a   Difrancesco, Dario ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Biological pacemaker; Bradycardia; Heart rate lowering agents; Pacemaker current

Indexed keywords

4 (N ETHYL N PHENYLAMINO) 1,2 DIMETHYL 6 (METHYLAMINO)PYRIMIDINIUM CHLORIDE; ALINIDINE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CARDIOVASCULAR AGENT; CILOBRADINE; DK AH 26; FALIPAMIL; IVABRADINE; PROTEIN; PROTEIN HCN2; UNCLASSIFIED DRUG; ZATEBRADINE;

DIASTOLE; HEART ARRHYTHMIA; HEART DEPOLARIZATION; HEART MUSCLE CELL; HEART RATE; HEART VENTRICLE HYPERTROPHY; HUMAN; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SINUS NODE MEMBRANE POTENTIAL; STABLE ANGINA PECTORIS; TISSUE DISTRIBUTION;

ANGINA PECTORIS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; CARDIAC PACING, ARTIFICIAL; CARDIOMEGALY; DIASTOLE; HEART CONDUCTION SYSTEM; HUMANS; ION CHANNELS; MYOCYTES, CARDIAC;

EID: 33846950337     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2006.00736.x     Document Type: Review

References (73)

1. Vinogradova TM, Bogdanov KY, Lakatta EG: beta-Adrenergic stimulation modulates ryanodine receptor Ca(2+) release during diastolic depolarization to accelerate pacemaker activity in rabbit sinoatrial nodal cells. Circ Res 2002;90:73-79.
2. DiFrancesco D, Robinson RB: Beta-modulation of pacemaker rate: Novel mechanism or novel mechanics of an old one? Circ Res 2002;90:E69-E69.
3. Bucchi A, Baruscotti M, Robinson RB, DiFrancesco D: I(f)-dependent modulation of pacemaker rate mediated by cAMP in the presence of ryanodine in rabbit sino-atrial node cells. J Mol Cell Cardiol 2003;35:905-913.
4. 2+ release sparks atrial pacemaker activity. New Physiol Sci 2001;16:101-106.
5. 2+ release is not a dominating factor in sinoatrial node pacemaker activity. Circ Res 2003;92:e41-e44.
6. Brown HF, DiFrancesco D, Noble SJ: How does adrenaline accelerate the heart? Nature 1979;280:235-236.
7. DiFrancesco D: The cardiac hyperpolarizing-activated current, if. Origins and developments. Prog Biophys Mol Biol 1985;46:163-183.
8. DiFrancesco D: Pacemaker mechanisms in cardiac tissue. Annu Rev Physiol 1993;55:455-472.
9. Accili EA, Proenza C, Baruscotti M, DiFrancesco D: From funny current to HCN channels: 20 years of excitation. New Physiol Sci 2002;17:32-37.
10. Robinson RB, Siegelbaum SA: Hyperpolarization-activated cation currents: From molecules to physiological function. Annu Rev Physiol 2003;65:453-480.
11. DiFrancesco D: Serious workings of the funny current. Prog Biophys Mol Biol 2006;90:13-25.
12. DiFrancesco D, Ferroni A, Mazzanti M, Tromba C: Properties of the hyperpolarizing-activated current (if) in cells isolated from the rabbit sino-atrial node. J Physiol (Lond) 1986;377:61-88.
13. DiFrancesco D, Tromba C: Muscarinic control of the hyperpolarization- activated current (if) in rabbit sino-atrial node myocytes. J Physiol (Lond) 1988;405:493-510.
14. DiFrancesco D, Ducouret P, Robinson RB: Muscarinic modulation of cardiac rate at low acetylcholine concentrations. Science 1989;243:669-671.
15. DiFrancesco D, Tortora P: Direct activation of cardiac pacemaker channels by intracellular cyclic AMP. Nature 1991;351:145-147.
16. Santoro B, Tibbs GR: The HCN gene family: Molecular basis of the hyperpolarization-activated pacemaker channels. Ann N Y Acad Sci 1999;868:741-764.
17. Biel M, Ludwig A, Zong X, Hofmann F: Hyperpolarization-activated cation channels: A multi-gene family. Rev Physiol Biochem Pharmacol 1999;136:165-181.
18. Viscomi C, Altomare C, Bucchi A, Camatini E, Baruscotti M, Moroni A, DiFrancesco D: C terminus-mediated control of voltage and cAMP gating of hyperpolarization-activated cyclic nucleotide-gated channels. J Biol Chem 2001;276:29930-29934.
19. Ulens C, Tytgat J: Functional heteromerization of HCN1 and HCN2 pacemaker channels. J Biol Chem 2001;276:6069-6072.
20. Altomare C, Terragni B, Brioschi C, Milanesi R, Pagliuca C, Viscomi C, Moroni A, Baruscotti M, DiFrancesco D: Heteromeric HCN1-HCN4 channels: A comparison with native pacemaker channels from the rabbit sinoatrial node. J Physiol (Lond) 2003;549:347-359.
21. Brown HF, DiFrancesco D: Voltage clamp investigations of membrane currents underlying pacemaker activity in rabbit sino-atrial node. J Physiol (Lond) 1980;308:331-351.
22. DiFrancesco D, Ojeda C: Properties of the current if in the sino atrial node of the rabbit compared with those of the current iK2 in Purkinje fibres. J Physiol (Lond) 1980;308:353-367.
23. DiFrancesco D: A new interpretation of the pace-maker current in calf Purkinje fibres. J Physiol (Lond) 1981;314:359-376.
24. DiFrancesco D: A study of the ionic nature of the pace-maker current in calf Purkinje fibres. J Physiol (Lond) 1981;314:377-393.
25. DiFrancesco D: Characterization of single pacemaker channels in cardiac sino-atrial node cells. Nature 1986;324:470-473.
26. Robinson RB, Yu H, Chang F, Cohen IS: Developmental change in the voltage-dependence of the pacemaker current, if, in rat ventricle cells. Pflug Arch Eur J Phy 1997;433:533-535.
27. Cerbai E, Pino R, Sartiani L, Mugelli A: Influence of postnatal-development on I(f) occurrence and properties in neonatal rat ventricular myocytes. Cardiovasc Res 1999;42:416-423.
28. Cerbai E, Mugelli A: I(f) in non-pacemaker cells: Role and pharmacological implications. Pharmacol Res 2006;53:416-423.
29. Wit AL, Fenoglio JJ Jr, Wagner BM, Bassett AL: Electrophysiological properties of cardiac muscle in the anterior mitral valve leaflet and the adjacent atrium in the dog. Possible implications for the genesis of atrial dysrhythmias. Circ Res 1973;32:731-745.
30. Wit AL, Fenoglio JJ Jr, Hordof AJ, Reemtsma K: Ultrastructure and transmembrane potentials of cardiac muscle in the human anterior mitral valve leaflet. Circulation 1979;59:1284-1292.
31. Anumonwo JM, Delmar M, Jalife J: Electrophysiology of single heart cells from the rabbit tricuspid valve. J Physiol (Lond) 1990;425:145-167.
32. Chen YJ, Chen SA, Chang MS, Lin CI: Arrhythmogenic activity of cardiac muscle in pulmonary veins of the dog: Implication for the genesis of atrial fibrillation. Cardiovasc Res 2000;48:265-273.
33. Chen YJ, Chen SA, Chen YC, Yeh HI, Chan P, Chang MS, Lin CI: Effects of rapid atrial pacing on the arrhythmogenic activity of single cardiomyocytes from pulmonary veins: Implication in initiation of atrial fibrillation. Circulation 2001;104:2849-2854.
34. Greenwood IA, Prestwich SA: Characteristics of hyperpolarization- activated cation currents in portal vein smooth muscle cells. Am J Physiol-Cell Ph 2002;282:C744-C753.
35. Perez-Lugones A, McMahon JT, Ratliff NB, Saliba WI, Schweikert RA, Marrouche NF, Saad EB, Navia JL, McCarthy PM, Tchou P, Gillinov AM, Natale A: Evidence of specialized conduction cells in human pulmonary veins of patients with atrial fibrillation. J Cardiovasc Electrophysiol 2003;14:803-809.
36. Shi W, Wymore R, Yu H, Wu J, Wymore RT, Pan Z, Robinson RB, Dixon JE, McKinnon D, Cohen IS: Distribution and prevalence of hyperpolarization-activated cation channel (HCN) mRNA expression in cardiac tissues. Circ Res 1999;85:e1-e6.
37. Qu J, Altomare C, Bucchi A, DiFrancesco D, Robinson RB: Functional comparison of HCN isoforms expressed in ventricular and HEK 293 cells. Pflug Arch Eur J Phy 2002;444:597-601.
38. Yu H, Wu J, Potapova I, Wymore RT, Holmes B, Zuckerman J, Pan Z, Wang H, Shi W, Robinson RB, El Maghrabi MR, Benjamin W, Dixon J, McKinnon D, Cohen IS, Wymore R: MinK-related peptide 1: A beta subunit for the HCN ion channel subunit family enhances expression and speeds activation. Circ Res 2001;88:E84-E87.
39. Qu J, Kryukova Y, Potapova IA, Doronin SV, Larsen M, Krishnamurthy G, Cohen IS, Robinson RB: MiRP1 modulates HCN2 channel expression and gating in cardiac myocytes. J Biol Chem 2004;279;43497-43502.
40. Decher N, Bundis F, Vajna R, Steinmeyer K: KCNE2 modulates current amplitudes and activation kinetics of HCN4: Influence of KCNE family members on HCN4 currents. Pflug Arch Eur J Phy 2003;466:633-640.
41. Barbuti A, Gravante B, Riolfo M, Milanesi R, Terragni B, DiFrancesco D: Localization of pacemaker channels in lipid rafts regulates channel kinetics. Circ Res 2004;94:1325-1331.
42. Barbuti A, Terragni B, Brioschi C, DiFrancesco D: Localization of f-channels to caveolae mediates specific beta(2)-adrenergic receptor modulation of rate in sinoatrial myocytes. J Mol Cell Cardiol 2007;42:71-78.
43. Ashcroft FM: Ion Channels and Disease. New York: Academic Press; 2000.
44. Sanguinetti MC, Tristani-Firouzi M: hERG potassium channels and cardiac arrhythmia. Nature 2006;440:463-469.
45. Priori SG, Schwartz PJ, Napolitano C, Bloise R, Ronchetti E, Grillo M, Vicentini A, Spazzolini C, Nastoli J, Bottelli G, Folli R, Cappelletti D: Risk stratification in the long-QT syndrome. N Engl J Med 2003;348:1866-1874.
46. Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R, Sorrentino V, Danieli GA: Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 2001;103:196-200.
47. Baker K, Warren KS, Yellen G, Fishman MC: Defective "pacemaker" current (Ih) in a zebrafish mutant with a slow heart rate. Proc Natl Acad Sci USA 1997;94:4554-4559.
48. Schulze-Bahr E, Neu A, Friederich P, Kaupp UB, Breithardt G, Pongs O, Isbrandt D: Pacemaker channel dysfunction in a patient with sinus node disease. J Clin Invest 2003;111:1537-1545.
49. Ueda K, Nakamura K, Hayashi T, Inagaki N, Takahashi M, Arimura T, Morita H, Higashiuesato Y, Hirano Y, Yasunami M, Takishita S, Yamashina A, Ohe T, Sunamori M, Hiraoka M, Kimura A: Functional characterization of a trafficking-defective HCN4 mutation, D553N, associated with cardiac arrhythmia. J Biol Chem 2004;279:27194-27198.
50. Milanesi R, Baruscotti M, Gnecchi-Ruscone T, DiFrancesco D: Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel. N Engl J Med 2006;354:151-157.
51. Vaca L, Stieber J, Zong X, Ludwig A, Hofmann F, Biel M: Mutations in the S4 domain of a pacemaker channel alter its voltage dependence. FEBS Lett 2000;479:35-40.
52. Cerbai E, Barbieri M, Mugelli A: Characterization of the hyperpolarization-activated current, I(f), in ventricular myocytes isolated from hypertensive rats. J Physiol (Lond) 1994;481(Pt 3):585-591.
53. Cerbai E, Barbieri M, Mugelli A: Occurrence and properties of the hyperpolarization-activated current If in ventricular myocytes from normotensive and hypertensive rats during aging. Circulation 1996;94:1674-1681.
54. Fernandez-Velasco M, Goren N, Benito G, Blanco-Rivero J, Bosca L, Delgado C: Regional distribution of hyperpolarization-activated current (If) and hyperpolarization-activated cyclic nucleotide-gated channel mRNA expression in ventricular cells from control and hypertrophied rat hearts. J Physiol (Lond) 2003;553:395-405.
55. Cerbai E, Pino R, Porciatti F, Sani G, Toscano M, Maccherini M, Giunti G, Mugelli A: Characterization of the hyperpolarization-activated current, I(f), in ventricular myocytes from human failing heart. Circulation 1997;95:568-571.
56. Hoppe UC, Jansen E, Sudkamp M, Beuckelmann DJ: Hyperpolarization- activated inward current in ventricular myocytes from normal and failing human hearts. Circulation 1998;97:55-65.
57. Cerbai E, Sartiani L, DePaoli P, Pino R, Maccherini M, Bizzarri F, DiCiolla F, Davoli G, Sani G, Mugelli A: The properties of the pacemaker current I(F)in human ventricular myocytes are modulated by cardiac disease. J Mol Cell Cardiol 2001;33:441-448.
58. + currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ Res 1993;73:379-385.
59. Baruscotti M, Bucchi A, DiFrancesco D: Physiology and pharmacology of the cardiac pacemaker ("funny") current. Pharmacol Ther 2005;107:59-79.
60. DiFrancesco D, Camm JA: Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: A new therapeutic perspective in cardiovascular disease. Drugs 2004;64:1757-1765.
61. Borer JS, Fox K, Jaillon P, Lerebours G: Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: A randomized, double-blind, multicentered, placebo-controlled trial. Circulation 2003;107:817-823.
62. Tardif JC, Ford I, Tendera M, Bourassa MG, Fox K: Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina. Eur Heart J 2005;26:2529-2536.
63. Bois P, Bescond J, Renaudon B, Lenfant J: Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells. Br J Pharmacol 1996;118:1051-1057.
64. DiFrancesco D: Funny channels in the control of cardiac rhythm and mode of action of selective blockers. Pharmacol Res 2006;53:399-406.
65. Fox K, Ferrari R, Tendera M, Steg PG, Ford I: Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: The morBidity-mortality EvAlUaTion of the I(f) inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) study. Am Heart J 2006;152:860-866.
66. Qu J, Plotnikov AN, Danilo P Jr, Shlapakova I, Cohen IS, Robinson RB, Rosen MR: Expression and function of a biological pacemaker in canine heart. Circulation 2003;107:1106-1109.
67. Plotnikov AN, Sosunov EA, Qu J, Shlapakova IN, Anyukhovsky EP, Liu L, Janse MJ, Brink PR, Cohen IS, Robinson RB, Danilo P Jr, Rosen MR: Biological pacemaker implanted in canine left bundle branch provides ventricular escape rhythms that have physiologically acceptable rates. Circulation 2004;109:506-512.
68. Potapova I, Plotnikov A, Lu Z, Danilo P Jr, Valiunas V, Qu J, Doronin S, Zuckerman J, Shlapakova IN, Gao J, Pan Z, Herron AJ, Robinson RB, Brink PR, Rosen MR, Cohen IS: Human mesenchymal stem cells as a gene delivery system to create cardiac pacemakers. Circ Res 2004;94:952-959.
69. Kehat I, Khimovich L, Caspi O, Gepstein A, Shofti R, Arbel G, Huber I, Satin J, Itskovitz-Eldor J, Gepstein L: Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol 2004;22:1282-1289.
70. Xue T, Cho HC, Akar FG, Tsang SY, Jones SP, Marban E, Tomaselli GF, Li RA: Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: Insights into the development of cell-based pacemakers. Circulation 2005;111:11-20.
71. Qu J, Barbuti A, Protas L, Santoro B, Cohen IS, Robinson RB: HCN2 overexpression in newborn and adult ventricular myocytes: Distinct effects on gating and excitability. Circ Res 2001;89:E8-E14.
72. Rosen MR, Brink PR, Cohen IS, Robinson RB: Genes, stem cells and biological pacemakers. Cardiovasc Res 2004;64:12-23.
73. Satin J, Kehat I, Caspi O, Huber I, Arbel G, Itzhaki I, Magyar J, Schroder EA, Perlman I, Gepstein L: Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes. J Physiol (Lond) 2004;559:479-496.